These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13704815)

  • 1. Pharmacology of some substituted 2-thiohydantoins with particular reference to anticonvulsant properties.
    GESLER RM; LINTS CE; SWINYARD EA
    Toxicol Appl Pharmacol; 1961 Jan; 3():107-21. PubMed ID: 13704815
    [No Abstract]   [Full Text] [Related]  

  • 2. A search for new anticonvulsant compounds among 3-aryl-5-benzylidene derivatives of 2-thiohydantoin.
    Korohoda MJ; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(4):329-33. PubMed ID: 981022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant properties of some N-substituted hydantoins.
    WOLF HH; SWINYARD EA; GOODMAN LS
    J Pharm Sci; 1962 Jan; 51():74-6. PubMed ID: 14007935
    [No Abstract]   [Full Text] [Related]  

  • 4. 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents.
    Tompkins JE
    J Med Chem; 1986 May; 29(5):855-9. PubMed ID: 2939244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and search for anticonvulsive and hypoglycemic properties of novel 5-benzylidene derivatives of 3-o-chloro- and 3-o-methylbenzoyl-2-thiohydantoin.
    Kleinrok Z; Sermak W; Kozicka M
    Pol J Pharmacol Pharm; 1987; 39(3):237-44. PubMed ID: 3438210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Derivatives of 5,5-bis-(p-methoxyphenyl)hydantoin and of 5,5-diphenylthiohydantoin with elevated myolitic and local anesthetic activity].
    CHITI W; SUPERBI C; CHIARINI P
    Farmaco Sci; 1960 Dec; 15():809-20. PubMed ID: 14448691
    [No Abstract]   [Full Text] [Related]  

  • 7. A search for new anticonvulsants among 3-aryl-5-benzylidene-derivatives of 2-thiohydantoin.
    Musial L; Korohoda MJ; Szadowska A; Szmigielska H
    Acta Pol Pharm; 1972; 29(6):569-77. PubMed ID: 4670132
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticonvulsant properties of 1-(1-phenylcyclohexyl) piperidine-HC1 and certain other drugs.
    CHEN G; BOHNER B
    Proc Soc Exp Biol Med; 1961 Mar; 106():632-5. PubMed ID: 13692760
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithyroid action and molecular structure. I. A study of thiohydantoins and their methyl esters].
    CHEYMOL J; CHABRIER P; GAY Y
    Arch Int Pharmacodyn Ther; 1951 Aug; 87(3):321-33. PubMed ID: 14895194
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of 5-heptyl-2-thiohydantoin on experimental tuberculosis.
    FROELICH EJ
    Am Rev Tuberc; 1958 Jul; 78(1):74-82. PubMed ID: 13545523
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithyroid activity of thiohydantoins.
    KILPATRICK R; ELMORE DT; WOOD DR
    Br J Pharmacol Chemother; 1958 Sep; 13(3):350-6. PubMed ID: 13584742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and anticonvulsant activity of 3-(M-iodophenyl)-5-benzylidine deriviatives of 2-thiohydantoin].
    Dziedzic B; Szadowska A; Kamińska A
    Acta Pol Pharm; 1978; 35(4):423-8. PubMed ID: 707153
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of-anticonvulsant drugs on cortical and subcortical seizure discharges in cats.
    STROBOS RR; SPUDIS EV
    Arch Neurol; 1960 Apr; 2():399-406. PubMed ID: 13835255
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain 5-hydroxytryptamine and anticonvulsant activity.
    ANDERSON EG; MARKOWITZ SD; BONNYCASTLE DD
    J Pharmacol Exp Ther; 1962 May; 136():179-82. PubMed ID: 13861220
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticonvulsant effect of nialamide and diphenylhydantoin.
    P'AN SY; FUNDERBURK WH; FINGER KF
    Proc Soc Exp Biol Med; 1961 Dec; 108():680-3. PubMed ID: 14482985
    [No Abstract]   [Full Text] [Related]  

  • 16. 2-substituted-N5-(2'-aminophenyl)-4-thiohydantoic acids as aminopeptidase inhibitors with pro-antinociceptive activity.
    Yu Z; Williams PS; Patel A; Smith HJ; Sewell RD; Gonzalez JP
    Prog Clin Biol Res; 1990; 328():481-4. PubMed ID: 2406761
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of 3-aryl-2-thiohydantoin- and 3-arylhydantoin-5-acetic acids and screening of some of their pharmacological properties.
    Korohoda MJ; Bojarska AB; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(5):423-7. PubMed ID: 827740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel solid-phase synthesis of disubstituted (5-biphenyltetrazolyl) hydantoins and thiohydantoins targeting the growth hormone secretagogue receptor.
    Severinsen R; Lau JF; Bondensgaard K; Hansen BS; Begtrup M; Ankersen M
    Bioorg Med Chem Lett; 2004 Jan; 14(2):317-20. PubMed ID: 14698149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis of 5, 5-(dipyridyl-2)-hydantoins and 5, 5-(dipyridyl-2)-thiohydantoins].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1956 Apr; 289(4):223-6. PubMed ID: 13328078
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacologic properties of new 5-benzylidene derivatives of 3-m-nitrophenyl-2-thiohydantoin].
    Kleinrok Z; Kozicka M; Tobiasz-Otrebska K; Sermak W
    Ann Univ Mariae Curie Sklodowska Med; 1985; 40():169-76. PubMed ID: 3917076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.